|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 29, 112-118, Copyright © 1988 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
LJ McGuigan, HA Quigley, G Lutty, C Enger and E Young
Glaucoma Service, Wilmer Institute, Johns Hopkins Hospital, Baltimore, MD 21205.
Two drugs, D-penicillamine and daunorubicin, were tested for their effect on proliferation and collagen synthesis of cultured conjunctival fibroblasts. This cell type is likely responsible for scar formation and ultimate filter surgery failure in glaucoma patients. Both drugs were antiproliferative; however, D-penicillamine required 2000 times the concentration of daunorubicin to achieve a similar degree of inhibition. D-penicillamine had a more consistent effect on intracellular collagen synthesis than daunorubicin at the doses tested. In contrast, at concentrations of daunorubicin where all proliferation ceased, intracellular production and extracellular transport of collagen were maintained.
This article has been cited by other articles:
![]() |
W.-C. Hsu, M. H. Spilker, I. V. Yannas, and P. A. D. Rubin Inhibition of Conjunctival Scarring and Contraction by a Porous Collagen-Glycosaminoglycan Implant Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2404 - 2411. [Abstract] [Full Text] |
||||
![]() |
C. Heilmann, P. Schönfeld, T. Schlüter, R. Bohnensack, and W. Behrens-Baumann Effect of the cytostatic agent idarubicin on fibroblasts of the human Tenon's capsule compared with mitomycin C Br. J. Ophthalmol., August 1, 1999; 83(8): 961 - 966. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |